通过使用血管塞器进行干预性封闭,成功治疗了支气管
Jialong Zhang1, Yukang Chen1, Zongming Li1
1Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou 450052, PR China.
Radiology case reports
|December 29, 2025
概括
一种罕见的支气管囊被成功使用安装器血管塞 (AVP II) 治疗. 这种微创方法为在肝癌治疗后管理复杂的胆道并发症提供了一个新的选择.
科学领域:
- 肝胆道手术 肝胆道手术
- 干预性放射学 干预性放射学
- 肺部病理学 肺部病理学
背景情况:
- 肝细胞癌 (HCC) 复发可能导致复杂的并发症.
- 支气管是一种罕见但严重的疾病,通常伴有咳和胆管.
- 以前对HCC的治疗方法,包括手术和透管动脉化学栓塞 (TACE),可能会使患者易于形成囊.
研究的目的:
- 报告一个成功治疗支气管的病例.
- 要突出安普拉斯特血管塞 (AVP II) 在治疗这种罕见并发症中的实用性.
主要方法:
- 一名61岁的男性患者有HCC病史,出现了支气管的症状.
- 通过支气管镜检查证实了诊断,显示出胆汁泄漏.
- 治疗包括通过皮肤部署安装器血管塞 (AVP II) 以在光学指导下遮住.
主要成果:
- 安普拉斯特血管塞 (AVP II) 已成功部署,有效地关闭了支气管.
- 患者的胆囊和咳症状在手术后得到缓解.
- 在干预后没有报告任何直接的并发症.
结论:
- 用安普拉斯特血管塞 (AVP II) 进行内血管封闭是一种安全有效的支气管的治疗方法.
- 这种微创手术技术为选定的患者提供了对外科手术的有价值替代方案.
- 需要进一步的研究来确定这种方法的长期有效性和安全性.
相关概念视频
Mitral Stenosis III: Medical Management
535
Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
535
Aortic Regurgitation III: Medical Management
598
Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
598
Coronary Artery Disease V: Interprofessional Care
444
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
444

